|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,772.00 JPY | +0.52% |
|
+0.10% | +26.77% |
| Oct. 30 | Jefferies Downgrades Chugai Pharmaceutical to Hold From Buy, Adjusts Price Target to 7,700 Yen From 7,100 Yen | MT |
| Oct. 25 | Musk on top of Wall Street |  |
| Capitalization | 11,086B 72.7B 69.34B 64.29B 57.03B 103B 6,164B 114B 799B 296B 2,535B 273B 267B | P/E ratio 2024 * |
28.8x | P/E ratio 2025 * | 28x |
|---|---|---|---|---|---|
| Enterprise value | 10,257B 67.26B 64.15B 59.48B 52.76B 95.11B 5,703B 106B 739B 274B 2,345B 253B 247B | EV / Sales 2024 * |
8.86x | EV / Sales 2025 * | 8.55x |
| Free-Float |
-
| Yield 2024 * |
1.32% | Yield 2025 * | 1.44% |
More valuation ratios
* Estimated data
More news
Last Transcript: Chugai Pharmaceutical Co., Ltd
More recommendations
More press releases
More news
| 1 day | +1.29% | ||
| 1 week | +0.83% | ||
| Current month | +3.43% | ||
| 1 month | -8.09% | ||
| 3 months | +5.31% | ||
| 6 months | +37.08% | ||
| Current year | +27.74% |
1 week
6 652.00
6 875.00
1 month
6 270.007 476.00
Current year
4 572.007 869.00
1 year
4 572.007 869.00
3 years
3 191.007 869.00
5 years
3 173.337 869.00
10 years
954.007 869.00
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 61 | 2020-12-31 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 2024-03-27 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Motoo Ueno
BRD | Director/Board Member | 67 | 1993-02-28 |
Masayuki Oku
BRD | Director/Board Member | 80 | 2015-02-28 |
| Director/Board Member | 76 | 2017-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.57% | 16 M€ | +9.94% | ||
| 1.87% | 59 M€ | +23.49% | ||
| 1.59% | 33 M€ | +23.67% | ||
| 1.53% | 64,976 M€ | +19.79% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +1.22% | +0.83% | +27.41% | +82.12% | 72.9B | ||
| -0.44% | -2.13% | +33.10% | +226.05% | 720B | ||
| +1.00% | +1.02% | +18.20% | +110.47% | 488B | ||
| -1.74% | -3.75% | -5.04% | -11.39% | 359B | ||
| -0.74% | -3.93% | +16.81% | +38.97% | 310B | ||
| -1.24% | -2.06% | -3.86% | +37.36% | 255B | ||
| +0.83% | +0.55% | +1.03% | -32.12% | 231B | ||
| +0.25% | -2.34% | +4.11% | +28.62% | 208B | ||
| -0.92% | -5.46% | +3.80% | +17.79% | 201B | ||
| -0.85% | -1.76% | +1.59% | +29.65% | 148B | ||
| Average | +0.00% | -1.58% | +9.72% | +52.75% | 299.41B | |
| Weighted average by Cap. | -0.03% | -1.58% | +13.10% | +82.39% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 1,157B 7.59B 7.24B 6.71B 5.95B 10.73B 643B 11.92B 83.36B 30.87B 265B 28.5B 27.87B | 1,174B 7.7B 7.34B 6.81B 6.04B 10.89B 653B 12.1B 84.6B 31.33B 269B 28.93B 28.29B |
| Net income | 385B 2.53B 2.41B 2.23B 1.98B 3.57B 214B 3.97B 27.74B 10.27B 88.04B 9.49B 9.28B | 396B 2.6B 2.48B 2.3B 2.04B 3.67B 220B 4.08B 28.54B 10.57B 90.59B 9.76B 9.54B |
| Net Debt | -829B -5.44B -5.19B -4.81B -4.27B -7.69B -461B -8.54B -59.74B -22.12B -190B -20.43B -19.97B | -1,040B -6.82B -6.5B -6.03B -5.35B -9.64B -578B -10.71B -74.91B -27.74B -238B -25.62B -25.05B |
More financial data
* Estimated data
Employees
7,604
Sector
Pharmaceuticals
Calendar
2025-01-30
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-11 | 6,772.00 ¥ | +0.52% | 903,600 |
| 24-12-11 | 6,737.00 ¥ | 0.00% | 1,736,300 |
| 24-12-10 | 6,737.00 ¥ | -1.00% | 2,092,800 |
| 24-12-09 | 6,805.00 ¥ | +1.13% | 1,707,000 |
| 24-12-06 | 6,729.00 ¥ | -0.53% | 1,398,200 |
Delayed Quote Japan Exchange, December 11, 2024 at 08:02 pm EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
6,737.00JPY
Average target price
7,416.67JPY
Spread / Average Target
+10.09%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4519 Stock